• Strain isolated from feces from babies
  • Strain safe for human use: genome sequence (WGS) and safety data (antibiotic sensitivity) are available
  • Strain subjected to EU patent application and PCT
  • Strain stability in liofilized powder form available over 6 months

The strain was tested in vitro for the following features

  1. the strain is sensitive to 9 antibiotics according to EFSA standards
  2. the strain adheres to the Caco-2 epithelial intestinal cells
  3. the strain is able to ferment prebiotics (FOS, IMO and lactulose)
  4. the strain has antipathogenic activity, adhesive ability to intestinal cells, it survives the gastric and intestinal transit
  5. the strain is able to activate the immune system to prevent possible viral infection: in its viable forms it induces IL-12p70 secretion in PBMCs